Morgan Stanley
-
Trio prepare multi-billion-dollar listings that will put Korea ECM on a strong footing for next year -
Cancer drug developer raises funds for debut product
-
Pharmaceutical company adds access to healthcare to sustainable finance metrics
-
Son of the Korean conglomerate's founder trims stake through an overnight deal
-
Bold move to price deal late in the year pays off
-
Deal raised $3.2bn for wealth fund to reinvest
-
Roche, Merck, Ecolab bring big M&A deals
-
Capital increase will help the German property company finance the acquisition of Deutsche Wohnen
-
The Public Investment Fund will sell 120m shares for up to $3.7bn
-
-
Corporate bond market keeps going as investors look to put cash to work
-
Chinese property developers are driven to ECM as the debt market remains sealed
